Lifecore Biomedical Management
Management criteria checks 0/4
Lifecore Biomedical's CEO is Paul Josephs, appointed in May 2024, has a tenure of less than a year. total yearly compensation is $10.25M, comprised of 0.1% salary and 99.9% bonuses, including company stock and options. directly owns 1.47% of the company’s shares, worth $4.03M. The average tenure of the management team and the board of directors is 1.5 years and 0.7 years respectively.
Key information
Paul Josephs
Chief executive officer
US$10.2m
Total compensation
| CEO salary percentage | 0.1% |
| CEO tenure | less than a year |
| CEO ownership | 1.5% |
| Management average tenure | 1.5yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
Lifecore Biomedical: An Interesting CDMO Pure Play
Dec 01Lifecore Biomedical, Inc. (NASDAQ:LFCR) Soars 36% But It's A Story Of Risk Vs Reward
Nov 26
Lifecore Biomedical: Finally A 'Pure Play' CDMO Business
Nov 12Lifecore Biomedical: No Sale Soon Amidst Leverage And Uncertainty
Jun 24White Falcon Capital - Lifecore Biomedical: Potential For Rapid Growth In Earnings And FCF Surge
Apr 20Would Lifecore Biomedical (NASDAQ:LFCR) Be Better Off With Less Debt?
Jun 30Landec Non-GAAP EPS of -$0.32, revenue of $43.35M
Oct 06Landec receives Nasdaq's notification on delayed annual report filing
Sep 09Laughing Water Capital - Landec Corp. : A High Quality CDMO
Jul 27Landec (NASDAQ:LNDC) Takes On Some Risk With Its Use Of Debt
Jun 24Analysts Have Been Trimming Their Landec Corporation (NASDAQ:LNDC) Price Target After Its Latest Report
Apr 08Landec (NASDAQ:LNDC) Has A Somewhat Strained Balance Sheet
Mar 21CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Aug 25 2024 | n/a | n/a | US$6m |
| May 26 2024 | US$10m | US$11k | US$9m |
Compensation vs Market: Paul's total compensation ($USD10.25M) is above average for companies of similar size in the US market ($USD1.38M).
Compensation vs Earnings: Insufficient data to compare Paul's compensation with company performance.
CEO
Paul Josephs (59 yo)
less than a year
Tenure
US$10,247,057
Compensation
Mr. Paul Josephs is President, CEO & Director of Lifecore Biomedical, Inc. from May 20, 2024. Mr. Josephs is President & CEO of Woodstock Sterile Solutions, Inc. Mr. Josephs serves as Senior Vice President...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$10.25m | 1.47% $ 4.0m | |
| Advisor | less than a year | US$2.50m | 1.84% $ 5.0m | |
| CFO & Secretary | less than a year | no data | 0.15% $ 408.1k | |
| Director of Internal Audit & Chief Compliance Officer | no data | no data | no data | |
| Senior Vice President of Corporate Development & Partnerships | 3yrs | no data | no data | |
| Senior Vice President of Human Resources | less than a year | no data | no data | |
| Executive VP | 3yrs | no data | no data | |
| Senior Vice President of Information Technology | 3yrs | no data | no data | |
| President of Curation Foods | 2.4yrs | US$1.34m | 1.18% $ 3.2m | |
| Vice President | no data | US$460.69k | no data |
1.5yrs
Average Tenure
59yo
Average Age
Experienced Management: LFCR's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$10.25m | 1.47% $ 4.0m | |
| Independent Director | 6.3yrs | US$215.00k | 0.24% $ 658.9k | |
| Independent Chairman of the Board | 5.4yrs | US$220.00k | 0.16% $ 445.1k | |
| Independent Director | 4.3yrs | US$220.00k | 0.16% $ 443.3k | |
| Independent Director | less than a year | no data | 0.0081% $ 22.3k | |
| Independent Director | 2yrs | US$200.00k | 0.076% $ 208.6k | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
0.7yrs
Average Tenure
59yo
Average Age
Experienced Board: LFCR's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 06:27 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/08/25 |
| Annual Earnings | 2024/05/26 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lifecore Biomedical, Inc. is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Alexander Paris | Barrington Research Associates, Inc. |
| Michael Petusky | Barrington Research Associates, Inc. |
| Matthew Hewitt | Craig-Hallum Capital Group LLC |